Atlas Trials

A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome

Clinical trial NCT05098509 · TERMINATED

Trial details

NCT number
NCT05098509
Sponsor
Radius Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prader-Willi Syndrome
Start date
2022-04-13
Primary completion
2022-10-06
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.